实用肝脏病杂志 ›› 2024, Vol. 27 ›› Issue (6): 935-938.doi: 10.3969/j.issn.1672-5069.2024.06.034

• 肝脓肿 • 上一篇    下一篇

2型糖尿病合并细菌性肝脓肿患者临床特征分析*

伊芬秀, 伊芬锦, 娄仲雷   

  1. 810003 西宁市第二人民医院内分泌科(伊芬秀);心内科(伊芬锦);青海大学医学院附属医院感染性疾病科(娄仲雷)
  • 收稿日期:2024-02-06 出版日期:2024-11-10 发布日期:2024-11-07
  • 作者简介:伊芬秀,女,40岁,大学本科,主治医师。E-mail:15897140164@163.com
  • 基金资助:
    *青海省卫生健康委科研项目(编号:2023-wjzdx-95)

Clinical feature of patients with bacterial liver abscess and concurrent underlying type 2 diabetes mellitus

Yi Fenxiu, Yi Fenjin, Lou Zhonglei   

  1. Department of Endocrinology, Second People's Hospital, Xining 810003, Qinghai Province,China
  • Received:2024-02-06 Online:2024-11-10 Published:2024-11-07

摘要: 目的 探讨2型糖尿病(T2DM)合并细菌性肝脓肿(BLA)患者的临床特征,总结治疗经验。方法 2021年5月~2023年10月我院诊治的102例BLA患者,其中合并T2DM者41例。行血培养或脓液培养,进行感染细菌鉴定。给予抗生素联合穿刺抽脓或置管引流治疗。采用荧光免疫层析法检测血清白细胞介素-6(IL-6)、C反应蛋白(CRP)、降钙素原(PCT)和淀粉样蛋白A(SAA),采用胶乳免疫比浊法检测血清D-二聚体(D-D)。结果 合并T2DM组合并高血压和呼吸道感染比例分别为51.2%和36.6%,均显著高于未合并组(分别为18.0%和8.2%,P<0.05);合并T2DM组血清IL-6、CRP、PCT和SAA水平分别为344.3(155.0,511.9)pg/ml、180.9(82.1,270.7)mg/L、8.6(5.7,10.6)μg/L和19.3(14.2,25.5)mg/L,显著高于BLA组【分别为195.5(136.6,274.1)pg/ml、124.8(52.5,190.4)mg/L、2.2(1.4,2.7)μg/L和14.5(12.6,20.1)mg/L,P<0.05】;合并T2DM组肺炎克雷伯杆菌感染率为78.0%,显著高于BLA组的57.4%(P<0.05);合并T2DM的BLA患者置管引流和抗菌药物治疗时间分别为6(3,10)d和13(5,20)d,均显著长于BLA组【分别为4(2,8)d和10(4,16)d,P<0.05】;除合并T2DM组死亡1例(2.4%)外,两组均治愈。结论 合并T2DM的BLA患者可能更多地存在呼吸道感染,以肺炎克雷伯杆菌感染为主,但经抗感染和肝穿刺抽脓或置管引流治疗,总体疗效较好。

关键词: 细菌性肝脓肿, 2型糖尿病, 病原菌, 炎症因子, 临床特征

Abstract: Objective The aim of this study was to summarize the clinical feature of patients with bacterial liver abscess (BLA) and concurrent underlying type 2 diabetes mellitus(T2DM). Methods 102 consecutive patients with BLA, of which, with concurrent underlying T2DM in 41 cases, were encountered in our hospital between May 2021 and October 2023, and all received antibiotics and intra-purulent cavity catheterization and pus drainage. Blood and/or pus bacterial culture and identification were conducted. Serum interleukin-6 (IL-6),C-reactive protein (CRP), procalcitonin (PCT), amyloid A (SAA) and D-dimer (D-D) levels were detected. Results Concurrent blood hypertension and pulmonary infections in patients with BLA and T2DM were 51.2% and 36.6%, both significantly higher than 18.0% and 8.2% (P<0.05) in those with BLA without T2DM; serum IL-6, CRP, PCT and SAA levels in patients with BLA and T2DM were 344.3(155.0, 511.9)pg/ml, 180.9(82.1, 270.7)mg/L, 8.6(5.7, 10.6)μg/L and 19.3(14.2, 25.5)mg/L, all significantly higher than [195.5(136.6, 274.1)pg/ml,124.8(52.5,190.4)mg/L, 2.2(1.4, 2.7)μg/L and 14.5(12.6, 20.1)mg/L, respectively, P<0.05] in those with BLA; Klebsiella Pneumoniae infection rate in patients with BLA and T2DM was 78.0%, much higher than 57.4%(P<0.05) in patients with BLA; catheterization for pus drainage and antibiotics therapy in patients with BLA and T2DM lasted for 6(3,10)d and 13(5, 20)d, both much longer than [4(2, 8)d and 10(4, 16)d,P<0.05] in patients with BLA; all but one patient (2.4%) with BLA and T2DM who died recovered. Conclusion Pulmonary and Klebsiella pneumoniae infection is more common in patients with BLA and concurrent underlying T2DM, and antibiotics and intra-purulent cavity catheterization for pus drainage is efficacious with a satisfactory outcomes.

Key words: Bacterial liver abscess, Type 2 diabetes mellitus, Pathogenic bacteria, Inflammatory factors, Clinical feature